US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist

1.275
+0.035+2.82%

Trading Apr 16 14:56 ET

33.55MMarket Cap-3087P/E (TTM)

ImmunoPrecise Antibodies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

(Q1)Jul 31, 2022

(FY)Apr 30, 2022

(Q4)Apr 30, 2022

(Q3)Jan 31, 2022

Total revenue

18.63%6.15M

21.31%5.69M

6.72%20.67M

7.29%5.62M

7.39%5.17M

9.78%5.18M

2.20%4.69M

8.11%19.36M

7.42%5.24M

6.64%4.82M

Operating revenue

18.63%6.15M

21.31%5.69M

6.72%20.67M

7.29%5.62M

7.39%5.17M

9.78%5.18M

2.20%4.69M

8.11%19.36M

7.42%5.24M

6.64%4.82M

Cost of revenue

32.89%3.2M

30.90%2.89M

8.60%9.1M

18.56%2.28M

-0.99%2.21M

12.02%2.41M

6.15%2.21M

31.49%8.38M

-8.43%1.92M

133.89%2.23M

Gross profit

6.30%2.95M

12.75%2.8M

5.28%11.56M

0.75%3.34M

14.62%2.96M

7.92%2.78M

-1.08%2.48M

-4.81%10.98M

19.41%3.32M

-27.40%2.59M

Operating expense

-43.71%5.96M

-45.53%6.69M

43.85%39.78M

23.81%9.39M

9.70%7.52M

46.18%10.59M

108.83%12.28M

76.00%27.66M

44.54%7.58M

51.84%6.86M

Selling and administrative expenses

-9.01%4.23M

8.03%5.68M

29.71%23.42M

31.50%7.6M

26.45%5.48M

25.11%4.65M

30.63%5.25M

36.11%18.06M

28.41%5.78M

12.08%4.33M

-Selling and marketing expense

12.73%921K

4.01%1.06M

34.73%3.61M

8.10%934K

2.96%836K

41.84%817K

526.99%1.02M

287.55%2.68M

364.52%864K

275.93%812K

-General and administrative expense

-13.65%3.31M

9.00%4.61M

28.84%19.81M

35.62%6.66M

31.87%4.64M

22.05%3.83M

9.67%4.23M

22.29%15.38M

13.91%4.91M

-3.53%3.52M

Research and development costs

-79.27%1.04M

-92.74%449K

60.25%12.28M

-62.08%502K

-49.85%1.03M

64.32%5M

452.73%6.19M

288.20%7.66M

114.94%1.32M

--2.06M

Depreciation amortization depletion

-25.39%711K

-23.83%847K

119.27%4.41M

162.35%1.32M

105.78%1.03M

89.09%953K

65.97%1.11M

-26.45%2.01M

-17.97%502K

-31.33%502K

-Depreciation and amortization

-25.39%711K

-23.83%847K

119.27%4.41M

162.35%1.32M

105.78%1.03M

89.09%953K

65.97%1.11M

-26.45%2.01M

-17.97%502K

-31.33%502K

Other operating expenses

-14.29%-16K

-4.81%-283K

-342.67%-332K

-36.84%-26K

38.89%-22K

26.32%-14K

-485.71%-270K

96.68%-75K

96.04%-19K

55.56%-36K

Operating profit

61.50%-3.01M

60.27%-3.89M

-69.25%-28.22M

-41.73%-6.05M

-6.72%-4.56M

-67.27%-7.81M

-190.43%-9.8M

-299.26%-16.67M

-72.79%-4.27M

-347.69%-4.27M

Net non-operating interest income expense

477.78%208K

2,860.00%138K

23.71%240K

91.01%170K

-71.94%39K

357.14%36K

94.95%-5K

133.39%194K

119.65%89K

188.54%139K

Non-operating interest income

491.67%213K

--143K

-3.23%270K

80.73%197K

-75.63%39K

500.00%36K

----

-1.06%279K

139.64%109K

1,233.33%160K

Non-operating interest expense

--5K

0.00%5K

-64.71%30K

35.00%27K

--0

-95.15%5K

-90.15%85K

-88.76%20K

-87.57%21K

Other net income (expense)

-29.63%209K

-408.70%-71K

-64.03%227K

91.05%-17K

-114.79%-76K

318.38%297K

-94.68%23K

150.97%631K

82.55%-190K

646.81%514K

Gain on sale of security

-29.63%209K

-408.70%-71K

-64.03%227K

91.05%-17K

-114.79%-76K

318.38%297K

-94.64%23K

151.13%631K

82.11%-190K

635.42%514K

Income before tax

65.36%-2.59M

60.89%-3.83M

-75.11%-27.75M

-34.95%-5.9M

-27.00%-4.6M

-55.16%-7.48M

-221.63%-9.78M

-164.35%-15.85M

-8.90%-4.37M

-200.25%-3.62M

Income tax

125.40%32K

34.99%-262K

-238.44%-1.19M

-378.91%-767K

-50.00%104K

-166.32%-126K

-314.36%-403K

-35.99%861K

-73.07%275K

133.71%208K

Net income

64.33%-2.62M

62.00%-3.57M

-58.96%-26.56M

-10.44%-5.13M

-22.82%-4.7M

-46.76%-7.35M

-190.43%-9.38M

-127.64%-16.71M

7.73%-4.64M

-195.67%-3.83M

Net income continuous Operations

64.33%-2.62M

62.00%-3.57M

-58.96%-26.56M

-10.44%-5.13M

-22.82%-4.7M

-46.76%-7.35M

-190.43%-9.38M

-127.64%-16.71M

7.73%-4.64M

-195.67%-3.83M

Minority interest income

Net income attributable to the parent company

64.33%-2.62M

62.00%-3.57M

-58.96%-26.56M

-10.44%-5.13M

-22.82%-4.7M

-46.76%-7.35M

-190.43%-9.38M

-127.64%-16.71M

7.73%-4.64M

-195.67%-3.83M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

64.33%-2.62M

62.00%-3.57M

-58.96%-26.56M

-10.44%-5.13M

-22.82%-4.7M

-46.76%-7.35M

-190.43%-9.38M

-127.64%-16.71M

7.73%-4.64M

-195.67%-3.83M

Basic earnings per share

66.67%-0.1

63.16%-0.14

-25.88%-1.07

8.70%-0.21

5.00%-0.19

-15.38%-0.3

-123.53%-0.38

-88.89%-0.85

23.33%-0.23

-150.00%-0.2

Diluted earnings per share

66.67%-0.1

63.16%-0.14

-25.88%-1.07

8.70%-0.21

5.00%-0.19

-15.38%-0.3

-123.53%-0.38

-88.89%-0.85

23.33%-0.23

-150.00%-0.2

Dividend per share

Currency Unit

CAD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022	(Q1)Jul 31, 2022	(FY)Apr 30, 2022	(Q4)Apr 30, 2022	(Q3)Jan 31, 2022
Total revenue	18.63%6.15M	21.31%5.69M	6.72%20.67M	7.29%5.62M	7.39%5.17M	9.78%5.18M	2.20%4.69M	8.11%19.36M	7.42%5.24M	6.64%4.82M
Operating revenue	18.63%6.15M	21.31%5.69M	6.72%20.67M	7.29%5.62M	7.39%5.17M	9.78%5.18M	2.20%4.69M	8.11%19.36M	7.42%5.24M	6.64%4.82M
Cost of revenue	32.89%3.2M	30.90%2.89M	8.60%9.1M	18.56%2.28M	-0.99%2.21M	12.02%2.41M	6.15%2.21M	31.49%8.38M	-8.43%1.92M	133.89%2.23M
Gross profit	6.30%2.95M	12.75%2.8M	5.28%11.56M	0.75%3.34M	14.62%2.96M	7.92%2.78M	-1.08%2.48M	-4.81%10.98M	19.41%3.32M	-27.40%2.59M
Operating expense	-43.71%5.96M	-45.53%6.69M	43.85%39.78M	23.81%9.39M	9.70%7.52M	46.18%10.59M	108.83%12.28M	76.00%27.66M	44.54%7.58M	51.84%6.86M
Selling and administrative expenses	-9.01%4.23M	8.03%5.68M	29.71%23.42M	31.50%7.6M	26.45%5.48M	25.11%4.65M	30.63%5.25M	36.11%18.06M	28.41%5.78M	12.08%4.33M
-Selling and marketing expense	12.73%921K	4.01%1.06M	34.73%3.61M	8.10%934K	2.96%836K	41.84%817K	526.99%1.02M	287.55%2.68M	364.52%864K	275.93%812K
-General and administrative expense	-13.65%3.31M	9.00%4.61M	28.84%19.81M	35.62%6.66M	31.87%4.64M	22.05%3.83M	9.67%4.23M	22.29%15.38M	13.91%4.91M	-3.53%3.52M
Research and development costs	-79.27%1.04M	-92.74%449K	60.25%12.28M	-62.08%502K	-49.85%1.03M	64.32%5M	452.73%6.19M	288.20%7.66M	114.94%1.32M	--2.06M
Depreciation amortization depletion	-25.39%711K	-23.83%847K	119.27%4.41M	162.35%1.32M	105.78%1.03M	89.09%953K	65.97%1.11M	-26.45%2.01M	-17.97%502K	-31.33%502K
-Depreciation and amortization	-25.39%711K	-23.83%847K	119.27%4.41M	162.35%1.32M	105.78%1.03M	89.09%953K	65.97%1.11M	-26.45%2.01M	-17.97%502K	-31.33%502K
Other operating expenses	-14.29%-16K	-4.81%-283K	-342.67%-332K	-36.84%-26K	38.89%-22K	26.32%-14K	-485.71%-270K	96.68%-75K	96.04%-19K	55.56%-36K
Operating profit	61.50%-3.01M	60.27%-3.89M	-69.25%-28.22M	-41.73%-6.05M	-6.72%-4.56M	-67.27%-7.81M	-190.43%-9.8M	-299.26%-16.67M	-72.79%-4.27M	-347.69%-4.27M
Net non-operating interest income expense	477.78%208K	2,860.00%138K	23.71%240K	91.01%170K	-71.94%39K	357.14%36K	94.95%-5K	133.39%194K	119.65%89K	188.54%139K
Non-operating interest income	491.67%213K	--143K	-3.23%270K	80.73%197K	-75.63%39K	500.00%36K	----	-1.06%279K	139.64%109K	1,233.33%160K
Non-operating interest expense	--5K	0.00%5K	-64.71%30K	35.00%27K	--0	--0	-95.15%5K	-90.15%85K	-88.76%20K	-87.57%21K
Other net income (expense)	-29.63%209K	-408.70%-71K	-64.03%227K	91.05%-17K	-114.79%-76K	318.38%297K	-94.68%23K	150.97%631K	82.55%-190K	646.81%514K
Gain on sale of security	-29.63%209K	-408.70%-71K	-64.03%227K	91.05%-17K	-114.79%-76K	318.38%297K	-94.64%23K	151.13%631K	82.11%-190K	635.42%514K
Income before tax	65.36%-2.59M	60.89%-3.83M	-75.11%-27.75M	-34.95%-5.9M	-27.00%-4.6M	-55.16%-7.48M	-221.63%-9.78M	-164.35%-15.85M	-8.90%-4.37M	-200.25%-3.62M
Income tax	125.40%32K	34.99%-262K	-238.44%-1.19M	-378.91%-767K	-50.00%104K	-166.32%-126K	-314.36%-403K	-35.99%861K	-73.07%275K	133.71%208K
Net income	64.33%-2.62M	62.00%-3.57M	-58.96%-26.56M	-10.44%-5.13M	-22.82%-4.7M	-46.76%-7.35M	-190.43%-9.38M	-127.64%-16.71M	7.73%-4.64M	-195.67%-3.83M
Net income continuous Operations	64.33%-2.62M	62.00%-3.57M	-58.96%-26.56M	-10.44%-5.13M	-22.82%-4.7M	-46.76%-7.35M	-190.43%-9.38M	-127.64%-16.71M	7.73%-4.64M	-195.67%-3.83M
Minority interest income
Net income attributable to the parent company	64.33%-2.62M	62.00%-3.57M	-58.96%-26.56M	-10.44%-5.13M	-22.82%-4.7M	-46.76%-7.35M	-190.43%-9.38M	-127.64%-16.71M	7.73%-4.64M	-195.67%-3.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	64.33%-2.62M	62.00%-3.57M	-58.96%-26.56M	-10.44%-5.13M	-22.82%-4.7M	-46.76%-7.35M	-190.43%-9.38M	-127.64%-16.71M	7.73%-4.64M	-195.67%-3.83M
Basic earnings per share	66.67%-0.1	63.16%-0.14	-25.88%-1.07	8.70%-0.21	5.00%-0.19	-15.38%-0.3	-123.53%-0.38	-88.89%-0.85	23.33%-0.23	-150.00%-0.2
Diluted earnings per share	66.67%-0.1	63.16%-0.14	-25.88%-1.07	8.70%-0.21	5.00%-0.19	-15.38%-0.3	-123.53%-0.38	-88.89%-0.85	23.33%-0.23	-150.00%-0.2
Dividend per share
Currency Unit	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall